factors affecting posology No Further a Mystery
Having said that, There exists a minority of cases wherever the treatment method of EID using the ICOC chelation protocol involving DF or L1 or their mix is probably not feasible resulting from very low tolerability or toxic side effects for instance allergic reactions throughout parenteral infusion of DF or toxicity for instance L1 agranulocytosis